Novel bacteria associated with Alzheimer’s disease

Your gift will help the Human Microbiology Institute identify new microbes and infectious agents that could trigger the onset and progression of Alzheimer’s disease. Indeed, we have already made an important discovery in this area, as described in «Diseases of the microbiota» section.

Patients with Alzheimer’s disease need more than just ordinary research

Greater than 30 million people suffer from Alzheimer’s disease worldwide, and the number of Alzheimer’s patients is predicted to double every 20 years unless preventive measures are developed. To this end, the IHM is dedicated to searching for novel human pathogens and characterizing their putative roles in Alzheimer’s disease, as well as their contributions to the cross-talk between the microbiome and the human host, as it relates to Alzheimer’s disease pathogenesis. As such, your help will provide new opportunities for understanding the pathogenesis of Alzheimer’s, and may contribute to the development of methods for the prevention and treatment of this disease.